Skip to main content
Premium Trial:

Request an Annual Quote

Another Call for Another Investigation

The Biden Administration has called for another look into the origins of SARS-CoV-2, according to the Financial Times.

Some have posited that the virus may have originated through an accidental lab release, though experts largely say that the virus is more likely to have originated in bats before being passed through another, unknown animal before infecting humans. A recent World Health Organization-led investigation issued a report that found SARS-CoV-2 likely arose in bats and said that the "lab leak" theory was "extremely unlikely."

However, the US, UK, Japan, and other countries noted flaws with the investigation, particularly that investigators did not have full access to needed data and called for an additional, more transparent investigation. Similarly, more than a dozen researchers have also called for a new investigation, arguing that the previous one did not look into the lab leak theory as deeply as other possibilities and should not have ruled the idea out.

According to FT, this new call by the US for an additional investigation into the origins of SARS-CoV-2 comes on the heels of a Wall Street Journal report on the early days of the outbreak in Wuhan. The Journal reports that three researchers from the Wuhan Institute of Virology fell ill in November 2019 and had to be hospitalized, though it's unclear what was wrong with them.

Andy Slavitt, a White House coronavirus advisor, says at FT that the earlier WHO investigation was not thorough enough. "We need to get to the bottom of this and we need a completely transparent process from China," he tells it. "We need the WHO to assist in that matter. We don't feel like we have that now."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.